CHEMOTHERAPY IN HEAD AND NECK-CANCER WITH BLEOMYCIN, CISPLATINUM, AND METHOTREXATE

被引：2

作者：

DEITMER, T ^{[1
]}

URBANITZ, D ^{[1
]}

机构：

[1] ST BERNWARD KRANKENHAUS,MED KLIN 2,D-3200 HILDESHEIM,FED REP GER

来源：

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 1988年 / 114卷 / 06期

关键词：

D O I：

10.1007/BF00398192

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：644 / 646

页数：3

共 18 条

[1] TREATMENT OF SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK WITH CISPLATIN AND 5-FLUOROURACIL [J].

AMREIN, PC ;

WIETZMAN, SA .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (12) :1632-1639

[2]

Bassot V, 1986, Ann Otolaryngol Chir Cervicofac, V103, P73

[3] 3-YEAR RESULTS OF COMBINED MODALITY THERAPY IN LOCALLY ADVANCED, RESECTABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J].

BOHEIM, K ;

SPOENDLIN, H .

ACTA OTO-LARYNGOLOGICA, 1985, 100 (1-2) :134-139

[4]

COUGHLIN CT, 1984, CANCER TREAT REP, V68, P591

[5] A PROSPECTIVE EVALUATION OF 5-FLUOROURACIL PLUS CISPLATIN IN ADVANCED SQUAMOUS-CELL CANCER OF THE HEAD AND NECK [J].

DASMAHAPATRA, KS ;

CITRIN, P ;

HILL, GJ ;

YEE, R ;

MOHITTABATABAI, MA ;

RUSH, BF .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (11) :1486-1489

[6]

DECKER DA, 1983, CANCER, V51, P1353, DOI 10.1002/1097-0142(19830415)51:8<1353::AID-CNCR2820510805>3.0.CO

[7]

2-I

[8] INDUCTION CHEMOTHERAPY OF SQUAMOUS-CELL CARCINOMA OF THE OROPHARYNX AND HYPOPHARYNX WITH CISPLATINUM, BLEOMYCIN AND METHOTREXATE [J].

DEITMER, T ;

URBANITZ, D .

LARYNGOLOGIE RHINOLOGIE OTOLOGIE VEREINIGT MIT MONATSSCHRIFT FUR OHRENHEILKUNDE, 1986, 65 (01) :7-10

[9]

DRELICHMAN A, 1983, CANCER, V52, P399, DOI 10.1002/1097-0142(19830801)52:3<399::AID-CNCR2820520303>3.0.CO

[10]

2-1

← 1 2 →